Scholarlink

Background <p>In an era of increasing demands on healthcare services, the development of regional oncology networks including care pathways may be instrumental to improve the efficiency and quality of care. However, developing such networks involving numerous stakeholders and hospitals is challenging as no templates exist. This study evaluates the development of a large regional network with the objective to provide a practical template.</p> Methods <p>A multicentre survey was conducted between October 1, 2024 and January 31, 2025. Clinicians from the departments of medical oncology, surgery, gastroenterology, pathology, radiology, nuclear medicine, and radiotherapy at the 13 hospitals in the OncoNoVo+ regional oncology network were invited. The survey included open-ended, multiple-choice, and slider questions (score range 0–100 on a visual analogue scale), focusing on baseline characteristics (<i>n</i> = 7), functioning of the network and care pathways (<i>n</i> = 16), and the development process of the care pathways (<i>n</i> = 6).</p> Results <p>Overall, 216 medical specialists, researchers, nurse specialists, and case-managers from 13 hospitals developed six care pathways (esophagogastric, pancreatic, small intestinal, rectal, liver, and biliary tract cancer). In the survey, 135 (63%) clinicians participated. Median scores of 75 or higher were observed in nine out of 11 satisfaction statements. Highest scores were observed for statements about the importance of regional care pathways, the recommendation of pathways outside the region, and the effectiveness of the OncoNoVo+ app (median, 85 [IQR, 75 to 97], 85 [75 to 99], and 84 [75 to 95], respectively). Mentioned ‘essential factors for success’ included coordination, collaboration, technology, and mutual respect. ‘Improvement factors’ included clearer implementation, better communication, regular updates, and equal involvement across hospitals and specialties.</p> Conclusion <p>The multicenter development and maintenance of regional care pathways for patients with gastrointestinal cancers within a regional oncology network seems feasible and effective with high satisfaction among participating hospitals. Implementation, communication, and equal involvement of centers and medical specialties deserve utmost attention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月30日

查看全文
  • Britte H. E. A. ten Haaft,
  • Eefje van Kessel,
  • Mark I. van Berge Henegouwen,
  • Janneke E. van den Bergh,
  • Karen Bolhuis,
  • Serge E. Dohmen,
  • Joris I. Erdmann,
  • Anne M. van Geel,
  • Michael F. Gerhards,
  • Myrte Gorris,
  • Liesbeth M. Kager,
  • Liudmila L. Kodach,
  • Niels F. M. Kok,
  • Jan-Bart M. Koorstra,
  • Annelien E. Laeijendecker,
  • Johanna W. van Sandick,
  • Wilhelmina H. Schreurs,
  • Dirkje W. Sommeijer,
  • Rutger-Jan Swijnenburg,
  • Jurriaan B. Tuynman,
  • Joanne Verheij,
  • Eva Versteijne,
  • Ankie M. T. van der Velden,
  • Francine E. M. Voncken,
  • Caroline A. Wientjes,
  • Johanna W. Wilmink,
  • Barbara M. Zonderhuis,
  • Geert Kazemier,
  • Marc G. Besselink,
  • Berthe Aleman,
  • Daud Allajar,
  • Caroline Andeweg,
  • Chris Bakker,
  • Sandra Bakker,
  • Annemarieke Bartels-Rutten,
  • Barbara Bastiaansen,
  • Hanneke Beaumont,
  • Geerard Beets,
  • Regina Beets-Tan,
  • Anne-Marie van Berkel,
  • Mariska Bloedjes,
  • Karam Boparai,
  • Freek Brandts,
  • Michelle Bronk,
  • Gijs de Bruin,
  • Tineke Buffart,
  • Olivier Busch,
  • Djuna Cahen,
  • Myriam Chalabi,
  • Annemarie Conijn,
  • Maaike Corver,
  • Saskia Debets,
  • Evelien Dekker,
  • Otto van Delden,
  • Ahmet Demirkiran,
  • Sarah Derks,
  • Jolanda van Dieren,
  • Paul Drillenburg,
  • Mich Dunker,
  • Marc Engelbrecht,
  • Wietse Eshuis,
  • Arantza Farina Sarasqueta,
  • Sebastiaan Festen,
  • Debby Geijsen,
  • Nanette van Geloven,
  • Suzanne Gisbertz,
  • Marc Govaert,
  • Cecile Grootscholten,
  • Brechtje Grotenhuis,
  • Koen Hartemink,
  • Simone Havenith,
  • Mathijs Hendriks,
  • Yvonne Hilhorst,
  • Roel Hompes,
  • Karin Horsthuis,
  • Inge Huibregtse,
  • Edwin Jansen,
  • Frederik Jonker,
  • Cynthia Keijzer-Steur,
  • Lisa Klompenhouwer,
  • Heinz-Josef Klümpen,
  • Koert Kuhlmann,
  • Philomeen Kuijer,
  • Hanneke van Laarhoven,
  • Max Lahaye,
  • Doenja Lambregts,
  • Wytze Lameris,
  • Oren Lapid,
  • Monique van Leerdam,
  • Anja van Lent,
  • Monique Maas,
  • Hendrik Marsman,
  • Sybren Meijer,
  • Marco Mundt,
  • Gijsbert Musters,
  • Jakko Nieuwenhuijzen,
  • Loes Noteboom,
  • Steven Oosterling,
  • Donald van der Peet,
  • Henna Reigman,
  • Jorik Reimerink,
  • Marjolein Rentinck,
  • Firazia Rodjan,
  • Wout Rohof,
  • Pascale Schafrat,
  • Annuska Schoorlemmer,
  • Jolanda Schrama,
  • Ruth Smit,
  • Michelle Spaan,
  • Sacha Spoor,
  • Andre Sterk,
  • Sietze van Turenhout,
  • Alexander Veenhof,
  • Amabel Vehmeijer-Scherpenzeel,
  • Anthony van de Ven,
  • Kathelijn Versteeg,
  • Bart Verwer,
  • Manon van der Vlugt,
  • Rogier Voermans,
  • Thijs Vogten,
  • Ronald Vuylsteke,
  • Jan Hein van Waesberghe,
  • Ingrid Walhout,
  • Roy van Wanrooij,
  • Pim Weijenborg,
  • Mariëtte Weterman,
  • Thomas de Wijkerslooth,
  • Annelieke Willemsen,
  • Karlijn Woensdregt,
  • Annette van Zweeden,
  • Gerben Zwezerijnen

摘要

Background

In an era of increasing demands on healthcare services, the development of regional oncology networks including care pathways may be instrumental to improve the efficiency and quality of care. However, developing such networks involving numerous stakeholders and hospitals is challenging as no templates exist. This study evaluates the development of a large regional network with the objective to provide a practical template.

Methods

A multicentre survey was conducted between October 1, 2024 and January 31, 2025. Clinicians from the departments of medical oncology, surgery, gastroenterology, pathology, radiology, nuclear medicine, and radiotherapy at the 13 hospitals in the OncoNoVo+ regional oncology network were invited. The survey included open-ended, multiple-choice, and slider questions (score range 0–100 on a visual analogue scale), focusing on baseline characteristics (n = 7), functioning of the network and care pathways (n = 16), and the development process of the care pathways (n = 6).

Results

Overall, 216 medical specialists, researchers, nurse specialists, and case-managers from 13 hospitals developed six care pathways (esophagogastric, pancreatic, small intestinal, rectal, liver, and biliary tract cancer). In the survey, 135 (63%) clinicians participated. Median scores of 75 or higher were observed in nine out of 11 satisfaction statements. Highest scores were observed for statements about the importance of regional care pathways, the recommendation of pathways outside the region, and the effectiveness of the OncoNoVo+ app (median, 85 [IQR, 75 to 97], 85 [75 to 99], and 84 [75 to 95], respectively). Mentioned ‘essential factors for success’ included coordination, collaboration, technology, and mutual respect. ‘Improvement factors’ included clearer implementation, better communication, regular updates, and equal involvement across hospitals and specialties.

Conclusion

The multicenter development and maintenance of regional care pathways for patients with gastrointestinal cancers within a regional oncology network seems feasible and effective with high satisfaction among participating hospitals. Implementation, communication, and equal involvement of centers and medical specialties deserve utmost attention.